Business
RushNet Inc. Files Attorney Letter and Satisfies Pink Current Requirements
RushNet Inc. Files Attorney Letter and Satisfies Pink Current Requirements.
About this update from Rushnet, Inc.
[{"type":"text","content":"Alpharetta, GA / Accesswire / June 10, 2021 / RushNet, Inc (OTC PINK: RSHN) (“RushNet”) is pleased to announce with the filing of the Attorney Letter with respect to periods ending Dec 31, 2019, and 2020 all requirements have been satisfied to become Pink Current. In the coming days, the company should move to a Yield Sign due requirements being satisfied. At that time, OTCMarkets will conduct their review of the recent filings, and we expect the company to move Pink Current.About HeliosDx: heliosDX is a National Clinical Reference Laboratory offering High-Complexity Urine Drug Testing (UDT), Behavioral Drug Testing, Allergy Droplet Cards, Oral Fluids, Infectious Disease (PCR), and NGS Genetic Testing. We are contracted in 44 of the lower 48 states and looking to expand our reach and capabilities. Always staying ahead of the curve, by continually investing in our infrastructure with the most efficient scientific proven instruments, and latest cutting-edge software for patient and physician satisfaction. This allows heliosDX to provide physicians fast and accurate reporting meeting and exceeding industry benchmarks. We excel in patient and client care through physician designed panels that aid in testing compliance and reporting education.Contact: Ashley [email protected] (Under Development)@dx_heliosSafe Harbor NoticeCertain statements contained herein are “forward-looking statements” (as defined in the Private Securities Litigation Reform Act of 1995). The Companies caution that statements, and assumptions made in this news release constitute forward-looking statements and makes no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. These statements may address issues that involve significant risks, uncertainties, estimates made by management. Actual results could differ materially from current projections or implied results. The Companies undertake no obligation to revise these statements following the date of this news release.Investor caution/added risk for investors in companies claiming involvement in COVID-19 initiatives –On April 8, 2020, SEC Chairman Jay Clayton and William Hinman, the Director of the Division of Corporation Finance, issued a joint public statement on the importa...